{
  "id": 5311,
  "text": "N Engl J Med 1999;340:1154-1161.Available at: http://www.ncbi.nlm.nih.gov/pubmed/10202166.130.Morris M, Eifel PJ, Lu J, et al.Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: N Engl J Med 1999;340:1154-1161.Available at: http://www.ncbi.nlm.nih.gov/pubmed/10202166.130.Morris M, Eifel PJ, Lu J, et al.Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "根据目前的研究，对于高危宫颈癌患者，骨盆放疗联合同步化疗在疗效上优于单独进行骨盆及主动脉旁放疗。同步化疗与放疗的组合能够增强治疗的协同效应，改善局部控制率并同时降低远处转移的风险，从而显著提高患者的整体生存率。这种联合治疗方式在高危宫颈癌人群中已经被证明能够显著改善预后，是更为推荐的治疗选择。",
  "query": "**对于高危宫颈癌患者，骨盆放疗联合同步化疗与骨盆及主动脉旁放疗相比，哪种治疗方式更有效？**",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: **对于高危宫颈癌患者，骨盆放疗联合同步化疗与骨盆及主动脉旁放疗相比，哪种治疗方式更有效？**\n\n<reference text>: N Engl J Med 1999;340:1154-1161.Available at: http://www.ncbi.nlm.nih.gov/pubmed/10202166.130.Morris M, Eifel PJ, Lu J, et al.Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "根据目前的研究，对于高危宫颈癌患者，骨盆放疗联合同步化疗在疗效上优于单独进行骨盆及主动脉旁放疗。同步化疗与放疗的组合能够增强治疗的协同效应，改善局部控制率并同时降低远处转移的风险，从而显著提高患者的整体生存率。这种联合治疗方式在高危宫颈癌人群中已经被证明能够显著改善预后，是更为推荐的治疗选择。"
}